Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA versus those not on a GLP-1 RA.

(HealthDay News) — The prevalence of chronic kidney disease (CKD) is increasing globally, according to a study published online in The Lancet to coincide with Kidney Week, the annual meeting of the ...

Nighttime light independently associated with elevated measures of stress-related neural activity, arterial inflammation.

(HealthDay News) — For patients with acute coronary syndrome, targeted vitamin D 3 supplementation is associated with a reduced risk for follow-up myocardial infarction, according to a study presented ...

The VISIONARY trial is testing sibeprenlimab, a humanized IgG2 monoclonal antibody, in patients with IgA nephropathy, a population at high risk for kidney failure.

Individual patients may have substantial differences in their eGFRcr and eGFRcys for estimating kidney function, which has prognostic implications.

Although SGLT2 inhibitors are standard-of-care treatments for CKD, type 2 diabetes, and heart failure (HF), the drugs are underutilized in clinical practice.

The Liberation From Acute Dialysis (LIBERATE-D) randomized clinical trial tested the value of a conservative vs conventional hemodialysis strategy on recovery of kidney function in stable patients ...

Topline data were announced from a phase 3 study evaluating obinutuzumab in patients between 2 and 25 years of age with idiopathic nephrotic syndrome.

Smoking cessation after cancer diagnosis is linked to improved overall survival even for advanced cancers, according to a recent study.

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.